{"transactions":[{"id":739497,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T17:20:39.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":44000,"derivative":{"exercise_price":8.74,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-26-073584","document":"tm2617745-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465926073584/tm2617745-3_4seq1.xml","form_type":"4"}},{"id":739496,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T17:20:39.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 10, 2026, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":260933,"source":{"system":"sec-edgar","filing":"0001104659-26-073584","document":"tm2617745-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465926073584/tm2617745-3_4seq1.xml","form_type":"4"}},{"id":747722,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T17:30:33.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":17421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in full on June 3, 2027, subject to the Reporting Person's continued service to the Issuer through the vesting date, and will be settled upon the earliest to occur of (a) the Reporting Person's termination of service, (b) a change in control of the Company, or (c) the Reporting Person's death or disability. The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer."}],"balance_after":263831,"source":{"system":"sec-edgar","filing":"0001193125-26-259986","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000119312526259986/ownership.xml","form_type":"4"}},{"id":884397,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-24T18:13:03.000Z","date":"2026-02-20","kind":"purchase","planned":false,"acquired":true,"shares":60229,"price":7.66,"value":461354.14,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.64 to $7.69, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 43,559 shares transferred from the Lindstrom Family No 2 Limited Partnership to the reporting person."}],"balance_after":246933,"source":{"system":"sec-edgar","filing":"0001104659-26-019256","document":"tm267134-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465926019256/tm267134-1_4seq1.xml","form_type":"4"}},{"id":1111323,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T16:24:49.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":44000,"derivative":{"exercise_price":8.82,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-25-059388","document":"tm2517945-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465925059388/tm2517945-4_4seq1.xml","form_type":"4"}},{"id":1111322,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T16:24:49.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 11, 2025, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 43,559 shares owned indirectly by the reporting person that have previously been erroneously reported as directly owned."}],"balance_after":143145,"source":{"system":"sec-edgar","filing":"0001104659-25-059388","document":"tm2517945-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465925059388/tm2517945-4_4seq1.xml","form_type":"4"}},{"id":1131690,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-28T16:30:10.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":7374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in full on May 23, 2026, subject to the Reporting Person's continued service to the Issuer through the vesting date, and will be settled upon the earliest to occur of (a) the Reporting Person's termination of service, (b) a change in control of the Company, or (c) the Reporting Person's death or disability. The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer."}],"balance_after":246410,"source":{"system":"sec-edgar","filing":"0000950170-25-078369","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000095017025078369/ownership.xml","form_type":"4"}},{"id":1152104,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-12T20:50:46.000Z","date":"2025-05-08","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":6.96,"value":69600.0,"ownership":{"direct":true},"balance_after":172704,"source":{"system":"sec-edgar","filing":"0001104659-25-047435","document":"tm2514889-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465925047435/tm2514889-1_4seq1.xml","form_type":"4"}},{"id":1447984,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-26T19:30:15.000Z","date":"2024-07-24","kind":"grant","planned":false,"acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":36000,"derivative":{"exercise_price":7.91,"expiration_date":"2034-07-23","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001104659-24-083104","document":"tm2420266-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465924083104/tm2420266-5_4seq1.xml","form_type":"4"}},{"id":1447983,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-26T19:30:15.000Z","date":"2024-02-27","kind":"exercise","planned":false,"acquired":false,"shares":11363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 27, 2024, the reporting person exercised an option to purchase 11,363 shares of the Company's common stock. The option was granted on April 14, 2014, and vested over three years, vesting monthly beginning on the one-month anniversary of the Company's initial public offering."}],"balance_after":0,"derivative":{"exercise_price":8.8,"expiration_date":"2024-04-13","underlying":"Common Stock","underlying_shares":11363},"source":{"system":"sec-edgar","filing":"0001104659-24-083104","document":"tm2420266-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465924083104/tm2420266-5_4seq1.xml","form_type":"4"}},{"id":1447982,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-26T19:30:15.000Z","date":"2024-02-27","kind":"exercise","planned":false,"acquired":false,"shares":18939,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 27, 2024, the reporting person exercised an option to purchase 18,939 shares of the Company's common stock. The option was granted on April 14, 2014, and vested over four years, with 25% of the shares underlying the option vesting on April 11, 2015, and vesting monthly thereafter."}],"balance_after":0,"derivative":{"exercise_price":8.8,"expiration_date":"2024-04-13","underlying":"Common Stock","underlying_shares":18939},"source":{"system":"sec-edgar","filing":"0001104659-24-083104","document":"tm2420266-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465924083104/tm2420266-5_4seq1.xml","form_type":"4"}},{"id":1447981,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-26T19:30:15.000Z","date":"2024-07-24","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 24, 2024, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":162704,"source":{"system":"sec-edgar","filing":"0001104659-24-083104","document":"tm2420266-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465924083104/tm2420266-5_4seq1.xml","form_type":"4"}},{"id":1447980,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-26T19:30:15.000Z","date":"2024-02-27","kind":"exercise","planned":false,"acquired":true,"shares":11363,"price":8.8,"value":99994.4,"ownership":{"direct":true},"balance_after":150704,"source":{"system":"sec-edgar","filing":"0001104659-24-083104","document":"tm2420266-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465924083104/tm2420266-5_4seq1.xml","form_type":"4"}},{"id":1447979,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-26T19:30:15.000Z","date":"2024-02-27","kind":"exercise","planned":false,"acquired":true,"shares":18939,"price":8.8,"value":166663.2,"ownership":{"direct":true},"balance_after":139341,"source":{"system":"sec-edgar","filing":"0001104659-24-083104","document":"tm2420266-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465924083104/tm2420266-5_4seq1.xml","form_type":"4"}},{"id":1521970,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-09T16:30:49.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in full on May 7, 2025, subject to the Reporting Person's continued service to the Issuer through the vesting date, and will be settled upon the earliest to occur of (a) the Reporting Person's termination of service, (b) a change in control of the Company, or (c) the Reporting Person's death or disability. The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer."}],"balance_after":239036,"source":{"system":"sec-edgar","filing":"0000950170-24-057107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000095017024057107/ownership.xml","form_type":"4"}},{"id":1851811,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T19:05:11.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":36000,"derivative":{"exercise_price":5.31,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001104659-23-072402","document":"tm2318782-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465923072402/tm2318782-4_4seq1.xml","form_type":"4"}},{"id":1851810,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T19:05:11.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2023, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":120402,"source":{"system":"sec-edgar","filing":"0001104659-23-072402","document":"tm2318782-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465923072402/tm2318782-4_4seq1.xml","form_type":"4"}},{"id":1874518,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-30T16:57:20.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":33175,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in twelve (12) substantially equal monthly installments commencing June 25, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. The option was granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer."}],"balance_after":33175,"derivative":{"exercise_price":3.23,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":33175},"source":{"system":"sec-edgar","filing":"0000899243-23-014072","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000089924323014072/doc4.xml","form_type":"4"}},{"id":1874517,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-30T16:57:20.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":9288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in full on May 25, 2024, subject to the Reporting Person's continued service to the Issuer through the vesting date. The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer."}],"balance_after":217036,"source":{"system":"sec-edgar","filing":"0000899243-23-014072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000089924323014072/doc4.xml","form_type":"4"}},{"id":2147112,"issuer":{"id":4740,"kind":"organization","name":"HARROW, INC."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-03T18:02:11.000Z","date":"2022-09-30","kind":"sale","acquired":false,"shares":40000,"price":12.62,"value":504800.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a predetermined Rule 10b5-1 trading plan adopted by the reporting person during December 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.03 to $12.50, inclusive. The reporting person undertakes to provide to Harrow Health, Inc. (\"Harrow\"), any security holder of Harrow, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held by the Lindstrom Family Limited Partnership No 2, a limited partnership of which the reporting person is the 100% owner and sole general partner."}],"balance_after":26100,"source":{"system":"sec-edgar","filing":"0001493152-22-027463","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000149315222027463/ownership.xml","form_type":"4"}},{"id":2225192,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-21T20:07:18.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":26800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":26800,"derivative":{"exercise_price":3.43,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":26800},"source":{"system":"sec-edgar","filing":"0001104659-22-073148","document":"tm2218958-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465922073148/tm2218958-3_4seq1.xml","form_type":"4"}},{"id":2225191,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-21T20:07:18.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":8933,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 16, 2022, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":108402,"source":{"system":"sec-edgar","filing":"0001104659-22-073148","document":"tm2218958-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465922073148/tm2218958-3_4seq1.xml","form_type":"4"}},{"id":2235683,"issuer":{"id":4740,"kind":"organization","name":"HARROW, INC."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSU","published_at":"2022-06-10T18:04:11.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":13123,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Restricted Stock Units were received as a compensatory award for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service."}],"balance_after":13123,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13123},"source":{"system":"sec-edgar","filing":"0001493152-22-016479","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000149315222016479/ownership.xml","form_type":"4"}},{"id":2253028,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-27T19:54:51.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":15616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in twelve (12) substantially equal monthly installments commencing June 25, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.  The option was granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer."}],"balance_after":15616,"derivative":{"exercise_price":7,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":15616},"source":{"system":"sec-edgar","filing":"0000899243-22-020012","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000089924322020012/doc4.xml","form_type":"4"}},{"id":2253027,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T19:54:51.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":4285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in full on May 25, 2023, subject to the Reporting Person's continued service to the Issuer through the vesting date.  The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer."}],"balance_after":207748,"source":{"system":"sec-edgar","filing":"0000899243-22-020012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000089924322020012/doc4.xml","form_type":"4"}},{"id":2270003,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-16T16:13:12.000Z","date":"2022-05-12","kind":"exercise","acquired":false,"shares":9469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, representing a right to purchase a total of 9,469 shares, became exercisable over four years, with 25% of the shares underlying the option vesting on November 1, 2013 and 2.0833% vesting monthly thereafter."}],"balance_after":0,"derivative":{"exercise_price":1.22,"expiration_date":"2022-10-11","underlying":"Common Stock","underlying_shares":9469},"source":{"system":"sec-edgar","filing":"0001104659-22-061322","document":"tm2215653-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465922061322/tm2215653-2_4seq1.xml","form_type":"4"}},{"id":2270002,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-16T16:13:12.000Z","date":"2022-05-12","kind":"exercise","acquired":true,"shares":9469,"price":1.22,"value":11552.18,"ownership":{"direct":true},"balance_after":99469,"source":{"system":"sec-edgar","filing":"0001104659-22-061322","document":"tm2215653-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465922061322/tm2215653-2_4seq1.xml","form_type":"4"}},{"id":2558741,"issuer":{"id":4740,"kind":"organization","name":"HARROW, INC."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T19:31:42.000Z","date":"2021-09-24","kind":"sale","acquired":false,"shares":3900,"price":10.04,"value":39156.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2021 and was terminated by the reporting person on September 24, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.01 to $10.08, inclusive. The reporting person undertakes to provide to Harrow Health, Inc. (\"Harrow\"), any security holder of Harrow, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held by the Lindstrom Family Limited Partnership No. 2, a limited partnership of which the reporting person is the general partner."}],"balance_after":66100,"source":{"system":"sec-edgar","filing":"0001493152-21-023910","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000149315221023910/ownership.xml","form_type":"4"}},{"id":2565372,"issuer":{"id":4740,"kind":"organization","name":"HARROW, INC."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-17T17:15:37.000Z","date":"2021-09-16","kind":"sale","acquired":false,"shares":5840,"price":9.02,"value":52676.8,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.10, inclusive. The reporting person undertakes to provide to Harrow, any security holder of Harrow, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held by the Lindstrom Family Limited Partnership No. 2, a limited partnership of which the reporting person is the general partner."}],"balance_after":70000,"source":{"system":"sec-edgar","filing":"0001493152-21-023036","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000149315221023036/ownership.xml","form_type":"4"}},{"id":2565371,"issuer":{"id":4740,"kind":"organization","name":"HARROW, INC."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-17T17:15:37.000Z","date":"2021-09-15","kind":"sale","acquired":false,"shares":14160,"price":9.09,"value":128714.4,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.98 to $9.28, inclusive. The reporting person undertakes to provide to Harrow Health, Inc. (\"Harrow\"), any security holder of Harrow, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held by the Lindstrom Family Limited Partnership No. 2, a limited partnership of which the reporting person is the general partner."}],"balance_after":75840,"source":{"system":"sec-edgar","filing":"0001493152-21-023036","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000149315221023036/ownership.xml","form_type":"4"}},{"id":2653222,"issuer":{"id":4740,"kind":"organization","name":"HARROW, INC."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSU","published_at":"2021-06-28T20:58:44.000Z","date":"2021-06-25","kind":"grant","acquired":true,"shares":9644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Restricted Stock Units were received as a compensatory award for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service."}],"balance_after":9644,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9644},"source":{"system":"sec-edgar","filing":"0001493152-21-015459","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000149315221015459/ownership.xml","form_type":"4"}},{"id":2658612,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-22T20:01:49.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 100% of the securities on the first anniversary of the grant date."}],"balance_after":18000,"derivative":{"exercise_price":13.51,"expiration_date":"2031-06-17","underlying":"Common stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001104659-21-084298","document":"tm2120338-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465921084298/tm2120338-3_4seq1.xml","form_type":"4"}},{"id":2700598,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-21T21:05:37.000Z","date":"2021-05-20","kind":"sale","acquired":false,"shares":10000,"price":14.3,"value":143000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.23 to $14.39, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":90000,"source":{"system":"sec-edgar","filing":"0001104659-21-070642","document":"tm2117208-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465921070642/tm2117208-1_4seq1.xml","form_type":"4"}},{"id":2700597,"issuer":{"id":4740,"kind":"organization","name":"HARROW, INC."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-21T17:28:39.000Z","date":"2021-05-20","kind":"sale","acquired":false,"shares":10000,"price":10.75,"value":107500.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents shares held by the Lindstrom Family Limited Partnership No 2, a limited partnership of which the reporting person is the 100% owner and sole general partner."}],"balance_after":90000,"source":{"system":"sec-edgar","filing":"0001493152-21-012566","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000149315221012566/ownership.xml","form_type":"4"}},{"id":2702786,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-20T16:15:26.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":20847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve (12) substantially equal monthly installments commencing June 18, 2021, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":20847,"derivative":{"exercise_price":7.49,"expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":20847},"source":{"system":"sec-edgar","filing":"0000899243-21-020138","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000089924321020138/doc4.xml","form_type":"4"}},{"id":2949935,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-10T20:48:30.000Z","date":"2020-12-07","kind":"grant","acquired":true,"shares":32127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awarded to the Reporting Person on December 7, 2020 in connection with an amendment on the same date to the restricted stock awarded to him on July 22, 2020 to amend and extend the vesting schedule applicable to such award (the \"Original Award\"). In order to comply with tax laws and to recognize the Reporting Person's agreement to an extension of the overall vesting schedule of the Original Award, the Reporting Person was issued the restricted stock award, which represents 20% of the total number of shares subject to the Original Award. The restricted stock award will vest on the same amended vesting schedule applicable to the Original Award, which amended vesting schedule provides for vesting in quarterly installments over the approximately three-year period following the amendment date."}],"balance_after":203463,"source":{"system":"sec-edgar","filing":"0000899243-20-033394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000089924320033394/doc4.xml","form_type":"4"}},{"id":3098357,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-26T16:04:38.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 100% of the securities on the first anniversary of the grant date."}],"balance_after":18000,"derivative":{"exercise_price":8.75,"expiration_date":"2030-06-24","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001104659-20-077449","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465920077449/a4.xml","form_type":"4"}},{"id":3118394,"issuer":{"id":4740,"kind":"organization","name":"HARROW, INC."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSU","published_at":"2020-06-08T18:05:21.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":17006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Restricted Stock Units were received as a compensatory award for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service."}],"balance_after":17006,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":17006},"source":{"system":"sec-edgar","filing":"0001493152-20-010788","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000149315220010788/ownership.xml","form_type":"4"}},{"id":3213347,"issuer":{"id":147894,"kind":"organization","name":"TearLab Corp","symbol":"TEAR"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-03-12T16:38:36.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to the Option shall be vested and exercisable upon the date of grant."}],"balance_after":60000,"derivative":{"exercise_price":0.0312,"expiration_date":"2030-03-10","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001493152-20-003827","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299139/000149315220003827/ownership.xml","form_type":"4"}},{"id":3475917,"issuer":{"id":4740,"kind":"organization","name":"HARROW, INC."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSU","published_at":"2019-06-28T21:05:43.000Z","date":"2019-06-26","kind":"grant","acquired":true,"shares":9715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service."},{"field":"security","element":"securityTitle","label":"F2","text":"The Restricted Stock Units were received as a compensatory award for no consideration."}],"balance_after":9715,"derivative":{"exercise_price":0,"exercise_date":"2019-06-26","expiration_date":"2020-06-26","underlying":"Common Stock","underlying_shares":9715},"source":{"system":"sec-edgar","filing":"0001493152-19-009925","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000149315219009925/ownership.xml","form_type":"4"}},{"id":3491110,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-13T17:18:47.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 100% of the securities on the first anniversary of the grant date."}],"balance_after":18000,"derivative":{"exercise_price":3.9,"expiration_date":"2029-06-10","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001104659-19-035410","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465919035410/a4.xml","form_type":"4"}},{"id":3595181,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-14T16:14:40.000Z","date":"2019-03-13","kind":"purchase","acquired":true,"shares":56441,"price":4.33,"value":244389.53,"ownership":{"direct":true},"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001104659-19-014844","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465919014844/a4.xml","form_type":"4"}},{"id":3878516,"issuer":{"id":4740,"kind":"organization","name":"HARROW, INC."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSU","published_at":"2018-07-02T19:52:26.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":34091,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service."},{"field":"security","element":"securityTitle","label":"F2","text":"The Restricted Stock Units were received as a compensatory award for no consideration."}],"balance_after":34091,"derivative":{"exercise_price":0,"exercise_date":"2018-06-29","expiration_date":"2019-06-29","underlying":"Common Stock","underlying_shares":34091},"source":{"system":"sec-edgar","filing":"0001493152-18-009612","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000149315218009612/ownership.xml","form_type":"4"}},{"id":3892264,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T17:23:18.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 100% of the securities on the first anniversary of the grant date."}],"balance_after":18000,"derivative":{"exercise_price":8.14,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001104659-18-040493","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465918040493/a4.xml","form_type":"4"}},{"id":4280485,"issuer":{"id":4740,"kind":"organization","name":"HARROW, INC."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSU","published_at":"2017-06-15T18:01:45.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":15723,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Award of Restricted Stock Units vests quarterly in equal installments over a one year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service."},{"field":"security","element":"securityTitle","label":"F2","text":"The Restricted Stock Units were received as a compensatory award for no consideration."}],"balance_after":15723,"derivative":{"exercise_price":0,"exercise_date":"2017-06-13","expiration_date":"2018-06-13","underlying":"Common Stock","underlying_shares":15723},"source":{"system":"sec-edgar","filing":"0001493152-17-006715","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000149315217006715/form4.xml","form_type":"4"}},{"id":4297876,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-01T18:28:51.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 100% of the securities on the first anniversary of the grant date."}],"balance_after":13500,"derivative":{"exercise_price":10.71,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001104659-17-037007","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465917037007/a4.xml","form_type":"4"}},{"id":4340317,"issuer":{"id":4740,"kind":"organization","name":"HARROW, INC."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Purchase Warrant","published_at":"2017-05-01T16:34:56.000Z","date":"2017-04-27","kind":"other","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The non-exercisable period for the Purchase Warrant was waived by the Company in exchange for cash exercise, the original date the warrant became exercisable was June 27, 2017."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents a contribution to the Lindstrom Family Limited Partnership No 2, a limited partnership of which the reporting person is the 100% owner and sole general partner."}],"balance_after":0,"derivative":{"exercise_price":1.79,"exercise_date":"2017-04-27","expiration_date":"2019-12-27","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-17-004611","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000149315217004611/form4.xml","form_type":"4"}},{"id":4340316,"issuer":{"id":4740,"kind":"organization","name":"HARROW, INC."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Purchase Warrant","published_at":"2017-05-01T16:34:56.000Z","date":"2017-04-27","kind":"gift","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents a contribution to the Lindstrom Family Limited Partnership No 2, a limited partnership of which the reporting person is the 100% owner and sole general partner."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The non-exercisable period for the Purchase Warrant was waived by the Company in exchange for cash exercise, the original date the warrant became exercisable was June 27, 2017."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents a contribution to the Lindstrom Family Limited Partnership No 2, a limited partnership of which the reporting person is the 100% owner and sole general partner."}],"balance_after":100000,"derivative":{"exercise_price":1.79,"exercise_date":"2017-04-27","expiration_date":"2019-12-27","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-17-004611","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000149315217004611/form4.xml","form_type":"4"}},{"id":4340315,"issuer":{"id":4740,"kind":"organization","name":"HARROW, INC."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Purchase Warrant","published_at":"2017-05-01T16:34:56.000Z","date":"2017-04-27","kind":"gift","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents a contribution to the Lindstrom Family Limited Partnership No 2, a limited partnership of which the reporting person is the 100% owner and sole general partner."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The non-exercisable period for the Purchase Warrant was waived by the Company in exchange for cash exercise, the original date the warrant became exercisable was June 27, 2017."}],"balance_after":0,"derivative":{"exercise_price":1.79,"exercise_date":"2017-04-27","expiration_date":"2019-12-27","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-17-004611","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000149315217004611/form4.xml","form_type":"4"}},{"id":4340314,"issuer":{"id":4740,"kind":"organization","name":"HARROW, INC."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-01T16:34:56.000Z","date":"2017-04-27","kind":"other","acquired":true,"shares":100000,"price":1.79,"value":179000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents a contribution to the Lindstrom Family Limited Partnership No 2, a limited partnership of which the reporting person is the 100% owner and sole general partner."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001493152-17-004611","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000149315217004611/form4.xml","form_type":"4"}},{"id":4514076,"issuer":{"id":4740,"kind":"organization","name":"HARROW, INC."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Purchase Warrant","published_at":"2016-12-21T16:04:40.000Z","date":"2016-12-19","kind":"purchase","acquired":true,"shares":100000,"price":0.125,"value":12500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 19, 2016 Dr. Lindstrom entered into a definitive agreement to acquire 100,000 Units of Imprimis Pharmaceuticals, Inc.'s (the \"Company\"), with each Unit consisting of one share of common stock, and a warrant to purchase one  share of the Company's common stock, as part of a private placement by the Company to accredited investors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The value of the Purchase Warrant included in each Unit is $0.125."}],"balance_after":100000,"derivative":{"exercise_price":1.79,"exercise_date":"2016-06-23","expiration_date":"2019-12-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-16-016104","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000149315216016104/form4.xml","form_type":"4"}},{"id":4514075,"issuer":{"id":4740,"kind":"organization","name":"HARROW, INC."},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-21T16:04:40.000Z","date":"2016-12-19","kind":"purchase","acquired":true,"shares":100000,"price":1.79,"value":179000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 19, 2016 Dr. Lindstrom entered into a definitive agreement to acquire 100,000 Units of Imprimis Pharmaceuticals, Inc.'s (the \"Company\"), with each Unit consisting of one share of common stock, and a warrant to purchase one  share of the Company's common stock, as part of a private placement by the Company to accredited investors."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001493152-16-016104","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000149315216016104/form4.xml","form_type":"4"}}]}